Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S; International Association of Pancreatology.

Pancreatology. 2006;6(1-2):17-32. Review.

2.

TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.

Rindi G, Falconi M, Klersy C, Albarello L, Boninsegna L, Buchler MW, Capella C, Caplin M, Couvelard A, Doglioni C, Delle Fave G, Fischer L, Fusai G, de Herder WW, Jann H, Komminoth P, de Krijger RR, La Rosa S, Luong TV, Pape U, Perren A, Ruszniewski P, Scarpa A, Schmitt A, Solcia E, Wiedenmann B.

J Natl Cancer Inst. 2012 May 16;104(10):764-77. doi: 10.1093/jnci/djs208. Epub 2012 Apr 23.

PMID:
22525418
3.

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD.

Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9.

5.

The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas.

Khannoussi W, Vullierme MP, Rebours V, Maire F, Hentic O, Aubert A, Sauvanet A, Dokmak S, Couvelard A, Hammel P, Ruszniewski P, Lévy P.

Pancreatology. 2012 May-Jun;12(3):198-202. doi: 10.1016/j.pan.2012.03.056. Epub 2012 Mar 20.

PMID:
22687372
6.

Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas.

Furukawa T, Kuboki Y, Tanji E, Yoshida S, Hatori T, Yamamoto M, Shibata N, Shimizu K, Kamatani N, Shiratori K.

Sci Rep. 2011;1:161. doi: 10.1038/srep00161. Epub 2011 Nov 18.

7.

Overview of the investigation and management of cystic neoplasms of the pancreas.

Spence RA, Dasari B, Love M, Kelly B, Taylor M.

Dig Surg. 2011;28(5-6):386-97. doi: 10.1159/000334758. Epub 2011 Dec 14. Review.

8.

Intraductal papillary mucinous neoplasms of the pancreas (IPMNs): epidemiology, diagnosis and future aspects.

Konstantinou F, Syrigos KN, Saif MW.

JOP. 2013 Mar 10;14(2):141-4. doi: 10.6092/1590-8577/1467. Review.

9.

Advances in the diagnosis of cystic neoplasms of the pancreas.

Kwon RS.

Curr Opin Gastroenterol. 2012 Sep;28(5):494-500. doi: 10.1097/MOG.0b013e3283567f3f. Review.

PMID:
22782021
10.

Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.

Matthaei H, Norris AL, Tsiatis AC, Olino K, Hong SM, dal Molin M, Goggins MG, Canto M, Horton KM, Jackson KD, Capelli P, Zamboni G, Bortesi L, Furukawa T, Egawa S, Ishida M, Ottomo S, Unno M, Motoi F, Wolfgang CL, Edil BH, Cameron JL, Eshleman JR, Schulick RD, Maitra A, Hruban RH.

Ann Surg. 2012 Feb;255(2):326-33. doi: 10.1097/SLA.0b013e3182378a18.

11.

Solid-pseudopapillary neoplasms of the pancreas: clinical and pathological features of 33 cases.

Cai H, Zhou M, Hu Y, He H, Chen J, Tian W, Deng Y.

Surg Today. 2013 Feb;43(2):148-54. doi: 10.1007/s00595-012-0260-3. Epub 2012 Jul 24.

PMID:
22825652
12.

Endoscopic ultrasound fine-needle aspiration characteristics of primary adenocarcinoma versus other malignant neoplasms of the pancreas.

Gagovic V, Spier BJ, DeLee RJ, Barancin C, Lindstrom M, Einstein M, Byrne S, Harter J, Agni R, Pfau PR, Frick TJ, Soni A, Gopal DV.

Can J Gastroenterol. 2012 Oct;26(10):691-6.

13.

Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

Salvia R, Fernández-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, Pederzoli P, Warshaw AL.

Ann Surg. 2004 May;239(5):678-85; discussion 685-7.

14.

Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease.

Werner J, Fritz S, Büchler MW.

Nat Rev Gastroenterol Hepatol. 2012 Mar 6;9(5):253-9. doi: 10.1038/nrgastro.2012.31. Review.

PMID:
22392299
15.

Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.

Ideno N, Ohtsuka T, Kono H, Fujiwara K, Oda Y, Aishima S, Ito T, Ishigami K, Tokunaga S, Ohuchida K, Takahata S, Nakamura M, Mizumoto K, Tanaka M.

Ann Surg. 2013 Jul;258(1):141-51. doi: 10.1097/SLA.0b013e31828cd008.

PMID:
23532108
16.

Invasive mucinous cystic neoplasms of the pancreas.

Baker ML, Seeley ES, Pai R, Suriawinata AA, Mino-Kenudson M, Zamboni G, Klöppel G, Longnecker DS.

Exp Mol Pathol. 2012 Dec;93(3):345-9. doi: 10.1016/j.yexmp.2012.07.005. Epub 2012 Aug 10.

PMID:
22902940
17.

Interdisciplinary management of cystic neoplasms of the pancreas.

Lee LS, Clancy T, Kadiyala V, Suleiman S, Conwell DL.

Gastroenterol Res Pract. 2012;2012:513163. doi: 10.1155/2012/513163. Epub 2012 Oct 21.

18.

Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.

Anand N, Sampath K, Wu BU.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):913-21; quiz e59-60. doi: 10.1016/j.cgh.2013.02.010. Epub 2013 Feb 13. Review.

PMID:
23416279
19.

The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.

Hirono S, Tani M, Kawai M, Okada K, Miyazawa M, Shimizu A, Kitahata Y, Yamaue H.

Ann Surg. 2012 Mar;255(3):517-22. doi: 10.1097/SLA.0b013e3182444231.

PMID:
22301608
20.

Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Yamaguchi H, Shimizu M, Ban S, Koyama I, Hatori T, Fujita I, Yamamoto M, Kawamura S, Kobayashi M, Ishida K, Morikawa T, Motoi F, Unno M, Kanno A, Satoh K, Shimosegawa T, Orikasa H, Watanabe T, Nishimura K, Ebihara Y, Koike N, Furukawa T.

Am J Surg Pathol. 2009 Aug;33(8):1164-72. doi: 10.1097/PAS.0b013e3181a162e5.

PMID:
19440145

Supplemental Content

Support Center